Thromboelastography: Potential bedside tool to assess the effects of antiplatelet therapy?

References

• Antithrombotics Trialists’ Collaboration. Prevention of death, myocardial infarction and stroke by antiplatelet therapy in high-risk patients. Br Med J 2002; 324: 71–86
   PubMed Web of Science ®Google Scholar
• Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Barrera-Ramirez C, Sabate M, Hernandez R, Moreno R, Escaned J, Alfonso F, Banuelos C, Costa MA, Bass TA, Macaya C. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting. Thromb Res. 2005; 115(1–2)101–108
   PubMed Web of Science ®Google Scholar
• Michelson AD. Platelet function testing in cardiovascular disease. Circulation 2004; 1110: e489–93
   Google Scholar
• Mallett SV, Cox DJ. Thrombelastography. Br J Anaesthesia 1992; 69: 307–313
   PubMed Web of Science ®Google Scholar
• Salooja N, Perry D. Thrombelastography. Blood Coagul Fibrinolysis 2001; 12: 327–337
   PubMed Web of Science ®Google Scholar
• Kang YG, Martin DJ, Marquez J, Lewis JH, Bontempo FA, Shaw BW, Starzl TE, Winter PM. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anaesthesia Analgesia 1985; 64: 888–896
   PubMed Web of Science ®Google Scholar
• Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thrombelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anaesthesia Analgesia 2003; 96(1)51–57
   PubMed Web of Science ®Google Scholar
• Kettner SC, Panzer OP, Kozek SA, Seibt FA, Stoiser B, Kofler J, Locker GJ, Zimpfer M. Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anaesthesia Analgesia 1999; 89(3)580–584
   PubMed Web of Science ®Google Scholar
• Samama CM. Thrombelastography: the next step. Anaesthesia Analgesia 2001; 92: 563–564
   PubMed Web of Science ®Google Scholar
• Christiaens L, Macchi L, Herpin D, Coisne D, Duplantier C, Allal J, Mauco G, Brizard A. Resistance to aspirin in vitro at rest and during exercise inpatients with angiographically proven coronary artery disease. Thromb Res 2002; 108(2–3)115–119
   PubMed Web of Science ®Google Scholar
• Andersen K, Hurlen M, Arnesen H, Seljeflot I. Aspirin non-responesiveness as measured by PFA-100 in patients with coronary artery disease. Thromb Res 2002; 108(1)37–42
   PubMed Web of Science ®Google Scholar
• Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003; 41(6)961–965
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002; 105(14)1650–1655
   PubMed Web of Science ®Google Scholar
• Grundmann K, Jashonek K, Kleine B, Dichgans J, Topka H. Aspirin non-responder status in patients with recurrent cerebrovascular ischemic attacks. J Neurol 2003; 250(1)63–66
   PubMed Web of Science ®Google Scholar
• Muller I, Besta F, Schulz C, Massberg S, Schonig A, Gawaz M. Prevalence of clopidogrel non-responders among patients with stable anginas pectoris scheduled for elective coronary stent placement. Throb Haemost 2003; 89(5)783–787
   PubMed Web of Science ®Google Scholar
• Jaremo P, Lindahl TL, Fransson SG, Richter A. Individual variations of platelet inhibition after loading doses of clopidogrel. J Intern Med 2002; 252(3)233–238
   PubMed Web of Science ®Google Scholar
• Colwell JA, Nair RM, Halushka PV, Rogers C, Whetsell A, Sagel J. Platelet adhesion and aggregation in diabetes mellitus. Metabolism 1979; 28(4 Suppl 1)394–400
   PubMed Web of Science ®Google Scholar
• Tamminen M, Lassila R, Westerbacka J, Vehkavaara S, Yki-Jarvine M. Obesity is associated with impaired platelet- inhibitory effect of acetylsalicylic acid in nondiabetic subjects. Int J Obes Relat Metab Disord 2003; 27(8)907–911
   PubMed Web of Science ®Google Scholar
• Gurbel P, Bliden K, Guyer K, Cho P, Zaman K, Kreutz R, Bassi A, Tantry U. Platelet reactivity in patients and recurrent events post-stenting. Results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 2005; 46: 1820–1826
   PubMed Web of Science ®Google Scholar
• Tantry U, Bliden K, Gurbel P. Overestimation of platelet aspirin resistance detection by thromboleastograph platelet mapping and validation by conventional aggreagometry using arachidonic acid stimulation. J Am Coll Cardiol 2005; 46: 170–179
   Google Scholar
• Carroll RC, Craft RM, Chavez JJ, Snider CC, Bresee SJ, Cohen E. A Thrombelastograph whole blood assay for clinical monitoring of NSAID-insensitive transcellular platelet activation by arachidonic acid. J Lab Clin Med 2005; 146(1)30–35
   PubMed Web of Science ®Google Scholar
• Craft RM, Chavez JJ, Snider CC, Muenchen RA, Carroll RC. Comparison of modified Thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med 2005; 145(6)309–315
   PubMed Web of Science ®Google Scholar
• Practical implementation of the guidelines for unstable angina/non ST elevation MI in the emergency department. AHA Scientific Statement. Circulation. 2005; 111: 2699–2710
   Google Scholar
• CURE Steering Committee. Effects of Clopidogrel in addition in patients with acute coronary syndromes without ST-segment elevation. New Engl J Med. 2001; 345: 494–502
   Google Scholar
• Guidelines for percutaneous coronary interventions. Taskforce on PCI for the European Society of Cardiology. Eur Heart J 2005; 26: 804–847
   PubMed Web of Science ®Google Scholar
• Bertand ME, Rupprecht HJ, Urban P, et al. Double-blind study of the safety of clopidogrel with or without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting. The clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000; 102: 624–629
   PubMed Web of Science ®Google Scholar
• Steinhubl SR, Berger PB, Mann JT. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomised controlled trial. J Am Med Assoc 2002; 288: 2411–2420
   PubMed Web of Science ®Google Scholar
• Kandzari DE, Berger PB, Kastrati A, et al. Influence of treatment duration with a 600 mg dose of clopidogrel before percutaneous coronary revascularisation. J Am Coll Cardiol 2004; 44: 2133–2136
   PubMed Web of Science ®Google Scholar
• Pappas JM, Westengard JC, Bull BS. Population Variability in the effect of aspirin on platelet function. Implications for clinical trials and therapy. Arch Pathol Lab Med 1994; 118: 801–804
   PubMed Web of Science ®Google Scholar
• Gum PA, Kottke-Marchant K, Welsh P, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003; 41(6)961–965
   PubMed Web of Science ®Google Scholar
• Jaremo P, Lindahl TL, Fransson SG, Richter A. Individual variations of platelet inhibition after loading doses of Clopidogrel. J Intern Med 2003; 252: 233–238
   Web of Science ®Google Scholar
• Gurbel PA, Bliden KP, Hiatt BL, O’Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pre-treatment platelet activity. Circulation 2003; 107(23)2908–2914
   PubMed Web of Science ®Google Scholar
• Wenaweser P, Dorffler-Melly J, Imboden K, et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 2005; 45: 1748–1752
   PubMed Web of Science ®Google Scholar
• Lev E, Bray P, Delao T, Grenada J, Kleiman N. Aspirin and clopidogrel drug response in patients undergoing PCI: a role for dual drug resistance?. J Am Coll Cardiol 2005; 45(3 suppl A)86A
   Web of Science ®Google Scholar
• Greilich PE, Carr ME, Cooley MV. Dose dependent effects of c7E3 Fab on modified Thrombelastograph analysis in healthy volunteers. Anesth Analg 1998; 86: S64
   Web of Science ®Google Scholar